What is the clinical evidence from this study?

Study design: Review. Population: Paroxysmal supraventricular tachycardia. Intervention: Mecholyl.

November 1, 1943Annals of Internal Medicine

The Management of Paroxysmal Tachycardia Including the Use of Mecholyl

View Full Paper

Ask AI

Bookmark

Key result

The provided excerpt discusses the management and potential severe sequelae of paroxysmal supraventricular tachycardia, without reporting specific quantitative study results.

Population

Patients with paroxysmal supraventricular tachycardia, particularly young adults without organic heart disease

Design

Review

Authors

PMPhilip W. MorganEmporia State University

Discussion

Member takes

Implication

Refractory PSVT may cause thrombosis or gangrene; leaves open optimal acute strategies with modern therapies.

Key Points

To evaluate the clinical presentation, complications, and medical management of paroxysmal supraventricular tachycardia, focusing on attacks refractory to standard interventions.
Synthesized clinical literature and case reports on patients experiencing paroxysmal supraventricular tachycardia resistant to routine mechanical maneuvers and oral medications.
Reviewed outcomes and therapeutic interventions, including vagal reflex stimulation and cholinergic drugs such as acetyl-beta-methylcholine (Mecholyl).
Observed that while most tachycardia attacks subside spontaneously, severe refractory attacks can persist for hours or days, causing marked reductions in pulse pressure and cardiac minute output.
Identified critical complications associated with sustained low perfusion during refractory attacks, including secondary arterial thrombosis leading to hemiplegia, peripheral gangrene, and death.

Structured PICO

Population

Patients with paroxysmal supraventricular tachycardia, particularly young adults without organic heart disease

Intervention

Methacholine (Mecholyl)

This historical article discusses the management of paroxysmal supraventricular tachycardia, including the use of methacholine for attacks resistant to ordinary physical means and oral therapy.

Cite This Study

Philip W. Morgan (1943) conducted a review in Paroxysmal supraventricular tachycardia. Mecholyl was evaluated. The provided excerpt discusses the management and potential severe sequelae of paroxysmal supraventricular tachycardia, without reporting specific quantitative study results.

synapsesocial.com/papers/6a9faabd9227262e5e90d5eb https://doi.org/10.7326/0003-4819-19-5-780

View Full Paper

Ask AI

Bookmark

The Management of Paroxysmal Tachycardia Including the Use of Mecholyl

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

The Management of Paroxysmal Tachycardia Including the Use of Mecholyl

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider